Compare ZURA & VOXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZURA | VOXR |
|---|---|---|
| Founded | 2022 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.9M | 293.7M |
| IPO Year | N/A | N/A |
| Metric | ZURA | VOXR |
|---|---|---|
| Price | $4.31 | $5.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $11.38 | N/A |
| AVG Volume (30 Days) | 369.0K | ★ 743.4K |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | ★ 0.97% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $12,158,304.00 |
| Revenue This Year | N/A | $43.78 |
| Revenue Next Year | N/A | $89.51 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 9.06 |
| 52 Week Low | $0.97 | $2.21 |
| 52 Week High | $4.68 | $5.54 |
| Indicator | ZURA | VOXR |
|---|---|---|
| Relative Strength Index (RSI) | 65.25 | 63.49 |
| Support Level | $3.88 | $4.90 |
| Resistance Level | $4.45 | $5.39 |
| Average True Range (ATR) | 0.25 | 0.25 |
| MACD | 0.05 | -0.03 |
| Stochastic Oscillator | 89.36 | 64.66 |
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
Vox Royalty Corp is a returns-focused mining royalty company with a portfolio of royalties and streams spanning eight jurisdictions. It has built intellectual property, a technically focused transactional team, and a sourcing network which has allowed Vox to target the highest returns on royalty acquisitions in the mining royalty sector. The company geographically operates Australia, Nigeria, USA, and Brazil.